Data / Form D filings / Sparrow Pharmaceuticals, Inc.
Sparrow Pharmaceuticals, Inc.: Form D filings
Sparrow Pharmaceuticals, Inc., a pharmaceuticals company in Portland, OR, filed 5 Form D notices with the SEC between 2019 and 2025. The latest, on July 1, 2025, reports $61.8 million sold of a $121.4 million offering to 17 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1050 Southwest 6th Street, Suite 1100, Portland, OR, 97204
- Phone
- (617) 465-0328
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1786949
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 1, 2025 | New notice | $121,400,027 | $61,841,225 | $59,558,802 | 17 | Jun 20, 2025 | sec.gov |
| Apr 12, 2024 | New notice | $15,251,730 | $10,000,000 | $5,251,730 | 4 | Apr 10, 2024 | sec.gov |
| Jan 13, 2021 | New notice | $50,825,257 | $1,075,255 | $49,750,002 | 15 | Dec 31, 2020 | sec.gov |
| Jun 26, 2020 | Amendment | $337,500 | $337,500 | 10 | Aug 21, 2018 | sec.gov | |
| Nov 15, 2019 | New notice | $8,000,000 | $270,000 | $7,730,000 | 10 | Aug 21, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jonathan Root | Director | |
| Niall O'Donnell | Director | |
| Zach Scheiner | Director | |
| Klaus Veitinger | Director | |
| Nanna L?neborg | Director | |
| Peter Thompson | Director | |
| Robert Jacks | Executive Officer, Director |
Other pharmaceuticals companies in Oregon that filed recently
- Spiritus, Inc. $66,061 · Oct 13, 2026
Every Form D from the week of Jun 30, 2025 · All recent filings in Oregon · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Sparrow Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.